BackKaruna Therapeutics Overview

Karuna Therapeutics Research & Development

Research & Development expenses for KRTX.

Quarterly R&D Expenses

$82.19M
↑ 24.53% YoY

As of Dec 31, 2023

Annual R&D Expenses (TTM)

$364.10M
↑ 62.37% YoY

Trailing 12 months ending Dec 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin